Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose ...

The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.

Chief Minister of Khyber Pakhtunkhwa, Ali Amin Khan Gandapur, has decided in principle to include the rehabilitation of drug addicts in the Sehat Card scheme and directed the relevant authorities to ...

More than 10 million babies have been born through IVF, yet the process is still invasive and costly. Plus, why a venture ...

Journavx is designed to eliminate the risks of addiction and overdose associated with medications like Vicodin and OxyContin.

With little fanfare, the Biden administration stacked a critical committee that helps set U.S. vaccination policy with new ...

The approval Journey Medical received from FDA for Emrosi makes DERM an exciting stock. Click here to read more.

This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of opioids.

Vertex has gained the FDA's approval for its non-addictive pain med Journavx, which becomes the first significant innovation ...

The Centers for Medicare and Medicaid Services ("CMS") published a final notice outlining the processes and procedures for the Transitional ...